Skip to main content
Top
Published in: BMC Health Services Research 1/2012

Open Access 01-12-2012 | Research article

Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis

Authors: John FP Bridges, Liming Dong, Gisselle Gallego, Barri M Blauvelt, Susan M Joy, Timothy M Pawlik

Published in: BMC Health Services Research | Issue 1/2012

Login to get access

Abstract

Background

Liver cancer is a complex and burdensome disease, with Asia accounting for 75% of known cases. Comprehensive cancer control requires the use of multiple strategies, but various stakeholders may have different views as to which strategies should have the highest priority. This study identified priorities across multiple strategies for comprehensive liver cancer control (CLCC) from the perspective of liver cancer clinical, policy, and advocacy stakeholders in China, Japan, South Korea and Taiwan. Concordance of priorities was assessed across the region and across respondent roles.

Methods

Priorities for CLCC were examined as part of a cross-sectional survey of liver cancer experts. Respondents completed several conjoint-analysis choice tasks to prioritize 11 strategies. In each task, respondents judged which of two competing CLCC plans, consisting of mutually exclusive and exhaustive subsets of the strategies, would have the greatest impact. The dependent variable was the chosen plan, which was then regressed on the strategies of different plans. The restricted least squares (RLS) method was utilized to compare aggregate and stratified models, and t-tests and Wald tests were used to test for significance and concordance, respectively.

Results

Eighty respondents (69.6%) were eligible and completed the survey. Their primary interests were hepatitis (26%), hepatocellular carcinoma (HCC) (58%), metastatic liver cancer (10%) and transplantation (6%). The most preferred strategies were monitoring at-risk populations (p<0.001), clinician education (p<0.001), and national guidelines (p<0.001). Most priorities were concordant across sites except for three strategies: transplantation infrastructure (p=0.009) was valued lower in China, measuring social burden (p=0.037) was valued higher in Taiwan, and national guidelines (p=0.025) was valued higher in China. Priorities did not differ across stakeholder groups (p=0.438).

Conclusions

Priorities for CLCC in Asia include monitoring at-risk populations, clinician education, national guidelines, multidisciplinary management, public awareness and centers of excellence. As most priorities are relatively concordant across the region, multilateral approaches to addressing comprehensive liver cancer would be beneficial. However, where priorities are discordant among sites, such as transplantation infrastructure, strategies should be tailored to local needs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Srivatanakul P, Sriplung H, Deerasamee S: Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev. 2004, 5: 118-125.PubMed Srivatanakul P, Sriplung H, Deerasamee S: Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev. 2004, 5: 118-125.PubMed
3.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. 2010, International Agency for Research on Cancer, Lyon, http://globocan.iarc.fr. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. 2010, International Agency for Research on Cancer, Lyon, http://​globocan.​iarc.​fr.
4.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Froman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Froman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed
6.
go back to reference Mohamed R, Desmond P, Suh DJ, Amarapurkar D, Gane E, Guangbi Y, Hou JL, Jafri W, Lai CL, Lee CH, Lee SD, Lim SG, Guan R, Phiet PH, Piratvisuth T, Sollano J, Wu JC: Practical difficulties in the management of hepatitis B in the Asia-pacific region. J Gastroenterol Hepatol. 2004, 19: 958-969. 10.1111/j.1440-1746.2004.03420.x.CrossRefPubMed Mohamed R, Desmond P, Suh DJ, Amarapurkar D, Gane E, Guangbi Y, Hou JL, Jafri W, Lai CL, Lee CH, Lee SD, Lim SG, Guan R, Phiet PH, Piratvisuth T, Sollano J, Wu JC: Practical difficulties in the management of hepatitis B in the Asia-pacific region. J Gastroenterol Hepatol. 2004, 19: 958-969. 10.1111/j.1440-1746.2004.03420.x.CrossRefPubMed
8.
go back to reference National cancer control programs in Korea. J Korean Med Sci. 2007, 22: S3-S4. National cancer control programs in Korea. J Korean Med Sci. 2007, 22: S3-S4.
9.
go back to reference Tsukuma H, Tanaka H, Ajiki W, Oshima A: Liver Cancer and its Prevention. Asian Pac J Cancer Prev. 2005, 6: 244-250.PubMed Tsukuma H, Tanaka H, Ajiki W, Oshima A: Liver Cancer and its Prevention. Asian Pac J Cancer Prev. 2005, 6: 244-250.PubMed
10.
go back to reference Yoshizawa H: National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology. 2006, 49: 7-17. 10.1159/000087257.CrossRefPubMed Yoshizawa H: National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population. Intervirology. 2006, 49: 7-17. 10.1159/000087257.CrossRefPubMed
11.
go back to reference Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR: A study of the awareness of chronic liver diseases among Korean adults. Korean J Hepatol. 2011, 17: 99-105. 10.3350/kjhep.2011.17.2.99.CrossRefPubMedPubMedCentral Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR: A study of the awareness of chronic liver diseases among Korean adults. Korean J Hepatol. 2011, 17: 99-105. 10.3350/kjhep.2011.17.2.99.CrossRefPubMedPubMedCentral
12.
go back to reference Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH: Management of hepatocellular carcinoma in Asia: consensus statement from the Asian oncology summit 2009. Lancet Oncol. 2009, 10: 1111-1118. 10.1016/S1470-2045(09)70241-4.CrossRefPubMed Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, Singh H, Chow WC, Ooi LL, Chow P, Khin MW, Koo WH: Management of hepatocellular carcinoma in Asia: consensus statement from the Asian oncology summit 2009. Lancet Oncol. 2009, 10: 1111-1118. 10.1016/S1470-2045(09)70241-4.CrossRefPubMed
13.
go back to reference WHO: National cancer control programmes: policies and managerial guidelines. 2002, World Health Organization, Geneva, 2 WHO: National cancer control programmes: policies and managerial guidelines. 2002, World Health Organization, Geneva, 2
14.
go back to reference Anderson BO, Distelhorst SR: Guidelines for international breast health and cancer control–implementation. Cancer. 2008, 113 (Suppl 8): 2215-2216.CrossRefPubMed Anderson BO, Distelhorst SR: Guidelines for international breast health and cancer control–implementation. Cancer. 2008, 113 (Suppl 8): 2215-2216.CrossRefPubMed
15.
go back to reference World Health Organization, Department of Reproductive Health and Research and Department of Chronic Diseases and Health Promotion: Comprehensive cervical cancer control: a guide to essential practice. 2006, World Health Organization, Geneva World Health Organization, Department of Reproductive Health and Research and Department of Chronic Diseases and Health Promotion: Comprehensive cervical cancer control: a guide to essential practice. 2006, World Health Organization, Geneva
16.
go back to reference Steger C, Daniel K, Gurian GL, Petherick JT, Stockmyer C, David AM, Miller SE: Public policy action and CCC implementation: benefits and hurdles. Cancer Causes Control. 2010, 21: 2041-2048. 10.1007/s10552-010-9668-5.CrossRefPubMedPubMedCentral Steger C, Daniel K, Gurian GL, Petherick JT, Stockmyer C, David AM, Miller SE: Public policy action and CCC implementation: benefits and hurdles. Cancer Causes Control. 2010, 21: 2041-2048. 10.1007/s10552-010-9668-5.CrossRefPubMedPubMedCentral
17.
go back to reference Bridges J, Joy S, Gallego G, Kudo M, Han K-H, Ye S-L, Cheng A-L, Blauvelt B: Needs for hepatocellular carcinoma (HCC) control policy in the Asia-pacific region. Asian Pac J Cancer Prev. 2011, 12: 2585-2591.PubMed Bridges J, Joy S, Gallego G, Kudo M, Han K-H, Ye S-L, Cheng A-L, Blauvelt B: Needs for hepatocellular carcinoma (HCC) control policy in the Asia-pacific region. Asian Pac J Cancer Prev. 2011, 12: 2585-2591.PubMed
18.
go back to reference Bridges J, Joy S, Gallego G, Blauvelt B, Geschwind JF, Pawlik T: Priorities for hepatocellular carcinoma (HCC) control: a comparison of policy needs in five European countries. J Comp Pol Anal. 2012, 14: 352-368. Bridges J, Joy S, Gallego G, Blauvelt B, Geschwind JF, Pawlik T: Priorities for hepatocellular carcinoma (HCC) control: a comparison of policy needs in five European countries. J Comp Pol Anal. 2012, 14: 352-368.
19.
go back to reference Oxman AD, Schünemann HJ, Fretheim A: Improving the use of research evidence in guideline development: 2. priority setting. Health Res Policy Syst. 2006, 4: 14-20. 10.1186/1478-4505-4-14.CrossRefPubMedPubMedCentral Oxman AD, Schünemann HJ, Fretheim A: Improving the use of research evidence in guideline development: 2. priority setting. Health Res Policy Syst. 2006, 4: 14-20. 10.1186/1478-4505-4-14.CrossRefPubMedPubMedCentral
20.
go back to reference Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. Dig Dis. 2011, 29: 339-364. 10.1159/000327577.CrossRefPubMed Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M: Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. Dig Dis. 2011, 29: 339-364. 10.1159/000327577.CrossRefPubMed
21.
go back to reference Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, Schoenfeld PS: Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011, 56: 569-577. 10.1007/s10620-010-1453-5.CrossRefPubMed Sharma P, Saini SD, Kuhn LB, Rubenstein JH, Pardi DS, Marrero JA, Schoenfeld PS: Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists. Dig Dis Sci. 2011, 56: 569-577. 10.1007/s10620-010-1453-5.CrossRefPubMed
22.
go back to reference Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR: A study of the awareness of chronic liver diseases among Korean adults. Korean Journal Hepatol. 2011, 17: 99-105. 10.3350/kjhep.2011.17.2.99.CrossRef Jun DW, Cho YK, Sohn JH, Lee CH, Kim SH, Eun JR: A study of the awareness of chronic liver diseases among Korean adults. Korean Journal Hepatol. 2011, 17: 99-105. 10.3350/kjhep.2011.17.2.99.CrossRef
23.
go back to reference Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009, 10: 35-43. 10.1016/S1470-2045(08)70284-5.CrossRefPubMed Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009, 10: 35-43. 10.1016/S1470-2045(08)70284-5.CrossRefPubMed
24.
go back to reference Masuoka HC, Rosen CB: Liver transplantation for hepatocellular carcinoma: expanding frontiers and building bridges. Clin Liver Dis. 2011, 15: 385-393. 10.1016/j.cld.2011.03.005.CrossRefPubMed Masuoka HC, Rosen CB: Liver transplantation for hepatocellular carcinoma: expanding frontiers and building bridges. Clin Liver Dis. 2011, 15: 385-393. 10.1016/j.cld.2011.03.005.CrossRefPubMed
25.
go back to reference Giacomin A, Cazzagon N, Sergio A, Vanin V, Farinati F: Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. Eur J Cancer Prev. 2011, 20: 381-388. 10.1097/CEJ.0b013e328346399b.CrossRefPubMed Giacomin A, Cazzagon N, Sergio A, Vanin V, Farinati F: Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. Eur J Cancer Prev. 2011, 20: 381-388. 10.1097/CEJ.0b013e328346399b.CrossRefPubMed
26.
go back to reference Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R: Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol. 2011, 18: 228-240.CrossRefPubMedPubMedCentral Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R: Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol. 2011, 18: 228-240.CrossRefPubMedPubMedCentral
27.
go back to reference Sibbald SL, Gibson JL, Singer PA, Upshur R, Martin DK: Evaluating priority setting success in healthcare: a pilot study. BMC Health Serv Res. 2010, 10: 131-144. 10.1186/1472-6963-10-131.CrossRefPubMedPubMedCentral Sibbald SL, Gibson JL, Singer PA, Upshur R, Martin DK: Evaluating priority setting success in healthcare: a pilot study. BMC Health Serv Res. 2010, 10: 131-144. 10.1186/1472-6963-10-131.CrossRefPubMedPubMedCentral
28.
go back to reference Goddard M, Hauck K, Smith PC: Priority setting in health - a political economy perspective. Health Econ Policy Law. 2006, 1: 79-90.CrossRefPubMed Goddard M, Hauck K, Smith PC: Priority setting in health - a political economy perspective. Health Econ Policy Law. 2006, 1: 79-90.CrossRefPubMed
30.
go back to reference Bridges JF: What can economics add to health technology assessment? please not just another cost-effectiveness analysis!. Expert Rev Pharmacoecon Outcomes Res. 2006, 6: 19-24. 10.1586/14737167.6.1.19.CrossRefPubMed Bridges JF: What can economics add to health technology assessment? please not just another cost-effectiveness analysis!. Expert Rev Pharmacoecon Outcomes Res. 2006, 6: 19-24. 10.1586/14737167.6.1.19.CrossRefPubMed
31.
go back to reference Bridges JF: Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003, 2: 213-224.PubMed Bridges JF: Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003, 2: 213-224.PubMed
32.
go back to reference Liu L, Rettenmaier AJ, Saving TR: Longevity bias in cost-effectiveness analysis. Health Econ. 2008, 17: 523-534. 10.1002/hec.1309.CrossRefPubMed Liu L, Rettenmaier AJ, Saving TR: Longevity bias in cost-effectiveness analysis. Health Econ. 2008, 17: 523-534. 10.1002/hec.1309.CrossRefPubMed
33.
go back to reference Drummond M, Sculpher M: Common methodological flaws in economic evaluations. Med Care. 2005, 43 (suppl 7): 5-14.PubMed Drummond M, Sculpher M: Common methodological flaws in economic evaluations. Med Care. 2005, 43 (suppl 7): 5-14.PubMed
34.
go back to reference Mitton C, Patten S: Evidence-based priority-setting: what do the decision-makers think?. J Health Serv Res Policy. 2004, 9: 146-152. 10.1258/1355819041403240.CrossRefPubMed Mitton C, Patten S: Evidence-based priority-setting: what do the decision-makers think?. J Health Serv Res Policy. 2004, 9: 146-152. 10.1258/1355819041403240.CrossRefPubMed
35.
go back to reference Dalkey N, Helmer O: An experimental application of the DELPHI method to the use of experts. Manag Sci. 1963, 9: 458-467. 10.1287/mnsc.9.3.458.CrossRef Dalkey N, Helmer O: An experimental application of the DELPHI method to the use of experts. Manag Sci. 1963, 9: 458-467. 10.1287/mnsc.9.3.458.CrossRef
36.
go back to reference Viergever RF, Olifson S, Ghaffar A, Terry RF: A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010, 8: 36-44.CrossRefPubMedPubMedCentral Viergever RF, Olifson S, Ghaffar A, Terry RF: A checklist for health research priority setting: nine common themes of good practice. Health Res Policy Syst. 2010, 8: 36-44.CrossRefPubMedPubMedCentral
37.
go back to reference Abelson J, Forest P-G, Eyles J, Smith P, Martin M, Gauvin F-P: Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003, 57: 239-251. 10.1016/S0277-9536(02)00343-X.CrossRefPubMed Abelson J, Forest P-G, Eyles J, Smith P, Martin M, Gauvin F-P: Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003, 57: 239-251. 10.1016/S0277-9536(02)00343-X.CrossRefPubMed
39.
go back to reference Vogt DS: Focus groups in psychological assessment: enhancing content validity by consulting members of the target population. Psychol Assess. 2004, 16 (3): 231-243.CrossRefPubMed Vogt DS: Focus groups in psychological assessment: enhancing content validity by consulting members of the target population. Psychol Assess. 2004, 16 (3): 231-243.CrossRefPubMed
40.
go back to reference Onwuegbuzie AJ, Leech NL: Validity and qualitative research: an oxymoron?. Qual Quant. 2007, 41: 233-249. 10.1007/s11135-006-9000-3.CrossRef Onwuegbuzie AJ, Leech NL: Validity and qualitative research: an oxymoron?. Qual Quant. 2007, 41: 233-249. 10.1007/s11135-006-9000-3.CrossRef
41.
go back to reference Armour A: The citizens’ jury model of public participation: a critical evaluation. Fairness and competence in citizen participation. Edited by: Renn O, Webler T, Wiedemann P. 1995, Kluwer Academic Publishers, Dordrecht, 175-185. Technology, risk, and society: an international series in risk analysis, vol 10CrossRef Armour A: The citizens’ jury model of public participation: a critical evaluation. Fairness and competence in citizen participation. Edited by: Renn O, Webler T, Wiedemann P. 1995, Kluwer Academic Publishers, Dordrecht, 175-185. Technology, risk, and society: an international series in risk analysis, vol 10CrossRef
42.
go back to reference Dolan JG: Multi-criteria clinical decision support: a primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare. Patient. 2010, 3: 229-248. 10.2165/11539470-000000000-00000.CrossRefPubMedPubMedCentral Dolan JG: Multi-criteria clinical decision support: a primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare. Patient. 2010, 3: 229-248. 10.2165/11539470-000000000-00000.CrossRefPubMedPubMedCentral
43.
go back to reference Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, Napper M, Robb CM: Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001, 5: 1-186.CrossRefPubMed Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, Napper M, Robb CM: Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001, 5: 1-186.CrossRefPubMed
44.
go back to reference Bridges JF, Slawik L, Schmeding A, Reimer J, Naber D, Kuhnigk O: A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia. Health Expect. 2011, 10.1111/j.1369-7625.2011.00704.x. Epub ahead of print Bridges JF, Slawik L, Schmeding A, Reimer J, Naber D, Kuhnigk O: A test of concordance between patient and psychiatrist valuations of multiple treatment goals for schizophrenia. Health Expect. 2011, 10.1111/j.1369-7625.2011.00704.x. Epub ahead of print
45.
go back to reference Bridges JF, Selck FW, Gray GE, McIntyre JA, Martinson NA: Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Plan. 2011, 26: 298-306. 10.1093/heapol/czq064.CrossRefPubMed Bridges JF, Selck FW, Gray GE, McIntyre JA, Martinson NA: Condom avoidance and determinants of demand for male circumcision in Johannesburg, South Africa. Health Policy Plan. 2011, 26: 298-306. 10.1093/heapol/czq064.CrossRefPubMed
46.
go back to reference Bridges JFP, Searle SC, Selck FW, Martinson NA: Engaging families in the choice of social marketing strategies for male circumcision services in Johannesburg, south Africa. Soc Market Q. 2010, 16: 60-76. 10.1080/15245004.2010.500443.CrossRef Bridges JFP, Searle SC, Selck FW, Martinson NA: Engaging families in the choice of social marketing strategies for male circumcision services in Johannesburg, south Africa. Soc Market Q. 2010, 16: 60-76. 10.1080/15245004.2010.500443.CrossRef
47.
go back to reference Flynn TN, Louviere JJ, Peters TJ, Coast J: Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007, 26: 171-189. 10.1016/j.jhealeco.2006.04.002.CrossRefPubMed Flynn TN, Louviere JJ, Peters TJ, Coast J: Best-worst scaling: what it can do for health care research and how to do it. J Health Econ. 2007, 26: 171-189. 10.1016/j.jhealeco.2006.04.002.CrossRefPubMed
48.
go back to reference McFadden D, In Frontiers in Econometrics: Conditional logit analysis of qualitative choice behavior. 1974, Edited by Zarembka P, New York: Academic Press, 105-142. McFadden D, In Frontiers in Econometrics: Conditional logit analysis of qualitative choice behavior. 1974, Edited by Zarembka P, New York: Academic Press, 105-142.
49.
go back to reference Thurstone LL: A law of comparative judgment. Psychol Rev. 1927, 34: 273-286.CrossRef Thurstone LL: A law of comparative judgment. Psychol Rev. 1927, 34: 273-286.CrossRef
50.
go back to reference Finn A, Louviere J: Determining the appropriate response to evidence of public concern: the case of food safety. Journal of Public Policy & Marketing. 1992, 11: 12-25. Finn A, Louviere J: Determining the appropriate response to evidence of public concern: the case of food safety. Journal of Public Policy & Marketing. 1992, 11: 12-25.
51.
go back to reference Street D, Street AP: Combinatorics of experimental design. 1987, Clarendon Press, Oxford Street D, Street AP: Combinatorics of experimental design. 1987, Clarendon Press, Oxford
52.
go back to reference Flynn TN: Using conjoint analysis and choice experiments to estimate QALY values: issues to consider. PharmacoEconomics. 2010, 28: 711-722. 10.2165/11535660-000000000-00000.CrossRefPubMed Flynn TN: Using conjoint analysis and choice experiments to estimate QALY values: issues to consider. PharmacoEconomics. 2010, 28: 711-722. 10.2165/11535660-000000000-00000.CrossRefPubMed
53.
go back to reference WHO: Cancer control: knowledge into action. WHO guide for effective programmes. 2006, World Health Organization, Geneva WHO: Cancer control: knowledge into action. WHO guide for effective programmes. 2006, World Health Organization, Geneva
54.
go back to reference Bridges JF, Gallego G, Kudo M, Okita K, Han KH, Ye SL, Blauvelt BM: Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res. 2011, 11: 298-309. 10.1186/1472-6963-11-298.CrossRefPubMedPubMedCentral Bridges JF, Gallego G, Kudo M, Okita K, Han KH, Ye SL, Blauvelt BM: Identifying and prioritizing strategies for comprehensive liver cancer control in Asia. BMC Health Serv Res. 2011, 11: 298-309. 10.1186/1472-6963-11-298.CrossRefPubMedPubMedCentral
55.
go back to reference Green PE, Srinivasan V: Conjoint analysis in consumer research: issues and outlook. J Consum Res. 1978, 5: 103-123. 10.1086/208721.CrossRef Green PE, Srinivasan V: Conjoint analysis in consumer research: issues and outlook. J Consum Res. 1978, 5: 103-123. 10.1086/208721.CrossRef
56.
go back to reference Lancsar E, Louviere J: Conducting discrete choice experiments to inform healthcare decision making: a user's guide. PharmacoEconomics. 2008, 26: 661-677. 10.2165/00019053-200826080-00004.CrossRefPubMed Lancsar E, Louviere J: Conducting discrete choice experiments to inform healthcare decision making: a user's guide. PharmacoEconomics. 2008, 26: 661-677. 10.2165/00019053-200826080-00004.CrossRefPubMed
58.
go back to reference Viney R, Lancsar E, Louviere J: Discrete choice experiments to measure consumer preferences for health and healthcare. Expert Rev Pharmacoecon Outcomes Res. 2002, 2: 319-326. 10.1586/14737167.2.4.319.CrossRefPubMed Viney R, Lancsar E, Louviere J: Discrete choice experiments to measure consumer preferences for health and healthcare. Expert Rev Pharmacoecon Outcomes Res. 2002, 2: 319-326. 10.1586/14737167.2.4.319.CrossRefPubMed
59.
go back to reference Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J: Conjoint analysis applications in health–a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011, 14: 403-413. 10.1016/j.jval.2010.11.013.CrossRefPubMed Bridges JF, Hauber AB, Marshall D, Lloyd A, Prosser LA, Regier DA, Johnson FR, Mauskopf J: Conjoint analysis applications in health–a checklist: a report of the ISPOR good research practices for conjoint analysis task force. Value Health. 2011, 14: 403-413. 10.1016/j.jval.2010.11.013.CrossRefPubMed
60.
go back to reference Bridges JFP, Buttorff C, Groothuis-Oudshoorn K: Estimating patients' preferences for medical devices: does the number of profiles in choice experiments matter?. NBER Working Paper. 2011, 17482. Bridges JFP, Buttorff C, Groothuis-Oudshoorn K: Estimating patients' preferences for medical devices: does the number of profiles in choice experiments matter?. NBER Working Paper. 2011, 17482.
61.
go back to reference Marshall D, Bridges JF, Hauber B, Cameron R, Donnalley L, Fyie K, Johnson FR: Conjoint analysis applications in health - how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient. 2010, 3: 249-256. 10.2165/11539650-000000000-00000.CrossRefPubMed Marshall D, Bridges JF, Hauber B, Cameron R, Donnalley L, Fyie K, Johnson FR: Conjoint analysis applications in health - how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008. Patient. 2010, 3: 249-256. 10.2165/11539650-000000000-00000.CrossRefPubMed
63.
go back to reference Dykstra RL: An algorithm for restricted least squares regression. J Am Statist Assoc. 1983, 78: 837-842. 10.1080/01621459.1983.10477029.CrossRef Dykstra RL: An algorithm for restricted least squares regression. J Am Statist Assoc. 1983, 78: 837-842. 10.1080/01621459.1983.10477029.CrossRef
64.
go back to reference Hauser JR, Rao VR, In Advances in Marketing Research: Conjoint analysis, related modeling, and applications. 2004, Progress and Prospects. Edited by Wind Y, Green PE, New York: Springer, 141-168. Hauser JR, Rao VR, In Advances in Marketing Research: Conjoint analysis, related modeling, and applications. 2004, Progress and Prospects. Edited by Wind Y, Green PE, New York: Springer, 141-168.
65.
go back to reference Angrist JD, Pischke J-S: Mostly harmless econometrics: an Empiricist’s companion. 2009, Princeton University Press, Princeton Angrist JD, Pischke J-S: Mostly harmless econometrics: an Empiricist’s companion. 2009, Princeton University Press, Princeton
66.
go back to reference Wang Q, Shi G, Chan-Halbrendt C: Market potential for fine furniture manufactured from low-grade hardwood: evidence from a conjoint analysis in the northeastern united states. Forest Prod J. 2004, 54: 19-25. Wang Q, Shi G, Chan-Halbrendt C: Market potential for fine furniture manufactured from low-grade hardwood: evidence from a conjoint analysis in the northeastern united states. Forest Prod J. 2004, 54: 19-25.
67.
go back to reference Chen DS: Hepatocellular carcinoma in Taiwan. Hepatol Res. 2007, 37: S101-S105. 10.1111/j.1872-034X.2007.00170.x.CrossRefPubMed Chen DS: Hepatocellular carcinoma in Taiwan. Hepatol Res. 2007, 37: S101-S105. 10.1111/j.1872-034X.2007.00170.x.CrossRefPubMed
68.
go back to reference Huang J: Ethical and legislative perspectives on liver transplantation in the People’s republic of china. Liver Transpl. 2007, 13: 193-196. 10.1002/lt.21081.CrossRefPubMed Huang J: Ethical and legislative perspectives on liver transplantation in the People’s republic of china. Liver Transpl. 2007, 13: 193-196. 10.1002/lt.21081.CrossRefPubMed
69.
go back to reference Wu J, Zheng SS: Liver transplantation in china: problems and their solutions. Hepatobiliary Pancreat Dis Int. 2004, 3: 170-174.PubMed Wu J, Zheng SS: Liver transplantation in china: problems and their solutions. Hepatobiliary Pancreat Dis Int. 2004, 3: 170-174.PubMed
Metadata
Title
Prioritizing strategies for comprehensive liver cancer control in Asia: a conjoint analysis
Authors
John FP Bridges
Liming Dong
Gisselle Gallego
Barri M Blauvelt
Susan M Joy
Timothy M Pawlik
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2012
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-12-376

Other articles of this Issue 1/2012

BMC Health Services Research 1/2012 Go to the issue